C Stathakis

477 total citations
25 papers, 325 citations indexed

About

C Stathakis is a scholar working on Epidemiology, Pharmacology and Surgery. According to data from OpenAlex, C Stathakis has authored 25 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Pharmacology and 5 papers in Surgery. Recurrent topics in C Stathakis's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Antibiotic Resistance in Bacteria (5 papers) and Renal Transplantation Outcomes and Treatments (3 papers). C Stathakis is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Antibiotic Resistance in Bacteria (5 papers) and Renal Transplantation Outcomes and Treatments (3 papers). C Stathakis collaborates with scholars based in Greece, United States and Switzerland. C Stathakis's co-authors include G. K. Daikos, J. Kosmidis, Dimitrios Stamatiadis, Paul Flowers, Maria Pothoulaki, Raymond MacDonald, Helen Giamarellou, Nikolaοs Tentolouris, Despoina Kyriaki and Ioannis Moyssakis and has published in prestigious journals such as Gut, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

C Stathakis

24 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C Stathakis Greece	11	107	91	53	52	41	25	325
Hartmuth Nowak Germany	11	89 0.8×	33 0.4×	10 0.2×	19 0.4×	31 0.8×	37	299
Aurore Wolak‐Thierry France	9	72 0.7×	41 0.5×	24 0.5×	7 0.1×	6 0.1×	12	289
J. Marey López Spain	8	211 2.0×	118 1.3×	45 0.8×	3 0.1×	32 0.8×	21	826
James Truong United States	15	202 1.9×	112 1.2×	53 1.0×	3 0.1×	16 0.4×	30	559
Prabha Adhikari India	12	48 0.4×	20 0.2×	21 0.4×	5 0.1×	3 0.1×	30	382
Sharon Remmelzwaal Netherlands	13	37 0.3×	17 0.2×	25 0.5×	10 0.2×	34 0.8×	37	459
Tavey Dorofaeff Australia	8	34 0.3×	43 0.5×	5 0.1×	5 0.1×	30 0.7×	14	278
David Andrae United States	10	85 0.8×	21 0.2×	8 0.2×	31 0.6×	12 0.3×	35	693
A Blumberg United States	9	110 1.0×	18 0.2×	4 0.1×	7 0.1×	6 0.1×	35	391
Kristi Prather United States	9	141 1.3×	62 0.7×	1 0.0×	13 0.3×	11 0.3×	14	365

Countries citing papers authored by C Stathakis

Since Specialization

Citations

This map shows the geographic impact of C Stathakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Stathakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Stathakis more than expected).

Fields of papers citing papers by C Stathakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Stathakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Stathakis. The network helps show where C Stathakis may publish in the future.

Co-authorship network of co-authors of C Stathakis

This figure shows the co-authorship network connecting the top 25 collaborators of C Stathakis. A scholar is included among the top collaborators of C Stathakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Stathakis. C Stathakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakopoulou, L., Andreas C. Lazaris, Ioannis Boletis, et al.. (2006). The expression of matrix metalloproteinase-11 protein in various types of glomerulonephritis. Nephrology Dialysis Transplantation. 22(1). 109–117. 6 indexed citations

Tentolouris, Nikolaοs, Konstantinos Makrilakis, D. Doulgerakis, et al.. (2005). Increased Plasma Ghrelin Levels in Chronic Renal Failure are not Associated with Hemodynamic Parameters. Hormone and Metabolic Research. 37(10). 646–652. 11 indexed citations

Tentolouris, Nikolaοs, D. Doulgerakis, Ioannis Moyssakis, et al.. (2004). Plasma Adiponectin Concentrations in Patients with Chronic Renal Failure: Relationship with Metabolic Risk Factors and Ischemic Heart Disease. Hormone and Metabolic Research. 36(10). 721–727. 42 indexed citations

Boletis, John, et al.. (2003). Beneficial effects of fluvastatin on progressive renal allograft dysfunction. Transplantation Proceedings. 35(4). 1364–1367. 7 indexed citations

Dhillon, S., et al.. (2002). Evaluation of Valaciclovir Dosage Reduction in Continuous Ambulatory Peritoneal Dialysis Patients. The Nephron journals/Nephron journals. 91(1). 164–166. 12 indexed citations

Boletis, John, et al.. (2001). Successful withdrawal of steroid after renal transplantation. Transplantation Proceedings. 33(1-2). 1231–1233. 16 indexed citations

Boletis, John, et al.. (2001). Monoclonal antibody basiliximab with low cyclosporine dose as initial immunosuppression. Transplantation Proceedings. 33(7-8). 3184–3186. 10 indexed citations

Stathakis, C, et al.. (1999). Acute Renal Failure in an Adult Patient with Henoch-Schoenlein Purpura After Episode of Macroscopic Hematuria. Renal Failure. 21(1). 107–111. 2 indexed citations

Nakopoulou, L., et al.. (1997). Acute renal failure associated with immunoglobulin administration. Nephrology Dialysis Transplantation. 12(7). 1497–1499. 15 indexed citations

10.

Boletis, John, et al.. (1993). Hepatitis C virus infection among Greek renal transplant patients.. Gut. 34(2 Suppl). S57–S58. 5 indexed citations

11.

Boletis, John, et al.. (1992). Antibodies against hepatitis C virus among renal transplant patients in Greece. PubMed. 5 Suppl 1. 51–53. 1 indexed citations

12.

Kostakis, A., Spiros D. Garbis, G. Zavos, et al.. (1991). Experience with triple immunosuppressive therapy in living related donor kidney transplantation.. PubMed. 23(4). 2223–2223. 3 indexed citations

13.

Stathakis, C, et al.. (1990). Cefetamet pivoxil in acute pyelonephritis: An open study. Current Medical Research and Opinion. 12(1). 43–50. 8 indexed citations

14.

Kneer, J, Robert A. Blouin, F J Frey, et al.. (1989). Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency. Antimicrobial Agents and Chemotherapy. 33(11). 1952–1957. 17 indexed citations

15.

Daikos, G. K., et al.. (1981). Ceftazidime: therapeutic results in various infections and kinetic studies. Journal of Antimicrobial Chemotherapy. 8(suppl B). 331–337. 27 indexed citations

16.

Daikos, G. K., et al.. (1980). Evaluation of cefotaxime in a hospital with high antibiotic resistance rates. Journal of Antimicrobial Chemotherapy. 6(suppl A). 255–261. 6 indexed citations

17.

Kosmidis, J., et al.. (1980). Clinical pharmacology of cefotaxime including penetration into bile, sputum, bone and cerebrospinal fluid. Journal of Antimicrobial Chemotherapy. 6(suppl A). 147–151. 22 indexed citations

18.

Kosmidis, J., et al.. (1979). Elimination kinetics of mezlocillin in normal and impaired renal function including the effects of dialysis.. PubMed. 29(12a). 1960–2. 5 indexed citations

19.

Kosmidis, J., et al.. (1977). Cefuroxime in Renal Insufficiency: Therapeutic Results in Various Infections and Pharmacokinetics Including the Effects of Dialysis. Proceedings of the Royal Society of Medicine. 70(9_suppl). 139–143. 8 indexed citations

20.

Daikos, G. K., et al.. (1977). Bioavailability of Cefuroxime in Various Sites including Bile, Sputum and Bone. Proceedings of the Royal Society of Medicine. 70(9_suppl). 38–41. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact